Interventional Cardiology

Leading minimally-invasive technologies for diagnosing and treating a variety of heart and vascular conditions.

We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.

Delivering Meaningful Innovation

A Pioneering Alternative to Blood Thinners. The WATCHMAN™ Left Atrial Appendage Closure Device is the only FDA-approved heart implant proven to reduce stroke risk in patients with non-valvular atrial fibrillation who need an alternative to long-term blood thinners. The WATCHMAN device is covered by Medicare and Medicaid Services for patients meeting certain coverage criteria.

Healing with Confidence. The SYNERGY™ Bioabsorbable Polymer Stent System is the first and only FDA-approved stent with a fast-absorbing bioabsorbable polymer coating to enable rapid healing and provide freedom from long-term polymer exposure. SYNERGY BP Stent is a meaningful step forward in drug-eluting stent technology.

Designed to Optimize TAVR. The ACURATE neo™ Aoritic Valve System* is a transcatheter aortic valve replacement (TAVR) technology that is designed to treat patients suffering from severe and symptomatic aortic valve stenosis who are considered at high risk for surgical valve replacement.

*The ACURATE neo™ Aortic Valve System is CE Marked. It is not available for sale or use in the U.S.